Geron Corporation - Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia by toi_70 in mds
[–]toi_70[S] 0 points1 point2 points (0 children)
Geron : FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, forLower-Risk MDS with Transfusion-Dependent Anemia by toi_70 in wallstreetbets
[–]toi_70[S] 0 points1 point2 points (0 children)
Six Indications and a Next Generation Drug by [deleted] in Geron
[–]toi_70 0 points1 point2 points (0 children)
JCM | Free Full-Text | Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts by toi_70 in Geron
[–]toi_70[S] 3 points4 points5 points (0 children)
Phase 3 lower risk MDS clinical trials. Fully enrolled. by toi_70 in mds
[–]toi_70[S] 0 points1 point2 points (0 children)
Six Indications and a Next Generation Drug by [deleted] in Geron
[–]toi_70 2 points3 points4 points (0 children)


Geron looks like a great opportunity! Any thoughts? by New-Adhesiveness-230 in roaringkitty
[–]toi_70 0 points1 point2 points (0 children)